Curis Inc. of Cambridge has licensed its Hedgehog proteins and novel small molecule Hedgehog pathway agonists (activators) to Wyeth Pharmaceuticals, a division of N.J.-based Wyeth, for therapeutic ...
An educational initiative will be launched tomorrow across the GCC and Levant to coincide with World Arthritis Day (WAD). The ...
NEW YORK, May 29 (Reuters) - U.S. health regulators have declined to immediately approve Wyeth's antibiotic Tygacil for treating pneumonia outside hospitals or nursing homes as they seek more data on ...
LITTLE ROCK, Ark. AP - Wyeth Pharmaceuticals will get a new trial to determine if the drugmaker should pay punitive damages to a woman who got breast cancer after taking hormone replacement therapy, a ...
January 21, 2005 — In mid-January, the US Food and Drug Administration (FDA) and Wyeth Pharmaceuticals sent out "Dear Doctor" and "Dear Pharmacist" letters notifying recipients that a new medication ...
Four months after beginning an early-stage study of its TRU-015 therapy in patients with non-Hodgkin's lymphoma, Trubion Pharmaceuticals said Thursday that its partner, Wyeth Pharmaceuticals, had ...
BOSTON, Dec 24 (Reuters) - Wyeth said on Monday it expects to revise its business plan and initiate cost cuts after Teva Pharmaceuticals Industries Ltd abruptly launched a generic rival to Wyeth's ...
21don MSN
Where Will Pfizer Be in 5 Years?
In five years, Pfizer will most likely be in a better position than it is today as a business. That's basically what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback